LogicBio Therapeutics has raised $45m in a series B financing, led by Arix Biosciences, bringing to $50m the total the recently launched firm has raised to complete preclinical development of an innovative gene therapy platform for pediatric diseases and move lead programs into clinical studies.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?